Delaware Valley Innovation Network Awards First Innovation Investment Grant to the Wistar...(nnovationnetwork.com . About the Wist...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Delaware Valley Innovation Network Awards First Innovation Investment Grant to the Wistar Institute
Date:7/1/2008
nnovationnetwork.com.
About the Wistar Institute
The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the country, Wistar has long held the prestigious Cancer Center designation from the National Cancer Institute. Discoveries at Wistar led to the creation of the rubella vaccine that eradicated the disease in the United States, human rabies vaccines used worldwide, and a rotavirus vaccine approved in 2006. Today, Wistar is home to preeminent research programs studying skin cancer, lung cancer, and brain tumors. Wistar Institute Vaccine Center scientists are creating new vaccines against pandemic influenza, HIV, and other diseases threatening global health. The Institute works actively to transfer its inventions to the commercial sector to ensure that research advances move from the laboratory to the clinic as quickly as possible. The Wistar Institute: Today's Discoveries - Tomorrow's Cures. On the web at http://www.wistar.org.
'/>"/>
| SOURCE Delaware Valley Innovation Network Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
4. Seneca Valley High School Student Receives Science Award From MedImmune
5. Align Technology, Inc. Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific & Medical Equipment, and Bio-Technology Companies
6. Agendias MammaPrint(R) Receives Prestigious Award From Dutch Innovation Platform
7. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
8. In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study
9. Coapt Systems New CEO, Laureen DeBuono, to Fuel Companys Growth and Product Innovation
10. Touch Bionics wins the 2008 MacRobert Award - i-LIMB Hand recognised as the leading engineering innovation of the year
11. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
Post Your Comments:
Breaking Biology Technology:Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 2Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 3Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 4Microfluidics Chairman James N. Little, Ph.D., Announces Retirement from Board of Directors 2Microfluidics Chairman James N. Little, Ph.D., Announces Retirement from Board of Directors 3Reportlinker Adds Pharmacodynamic Assays 2Reportlinker Adds Pharmacodynamic Assays 3Reportlinker Adds Pharmacodynamic Assays 4Eidogen-Sertanty Licenses TIP to the FDA 2
Other Biology Technology:Managing Risk Through Quality: Ansell Healthcare's Innovative Gammex(R) Glove Range on Display at Arab Health 2009 2WuXi PharmaTech to Present at 27th Annual J.P. Morgan Healthcare Conference 2Medarex to Present at the 27th Annual J.P. Morgan Healthcare Conference 2
Breaking Biology News(10 mins):CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2Supportive materials will help regenerate heart tissue 2UAB bone center director wins distinguished service award from clinical pathology society 2Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth 5106 1Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth 5106 2EMD Serono Submits Application for Cladribine Tablets as a Potential Oral Short Course Multiple Sclerosis Therapy in the United States 5104 1EMD Serono Submits Application for Cladribine Tablets as a Potential Oral Short Course Multiple Sclerosis Therapy in the United States 5104 2EMD Serono Submits Application for Cladribine Tablets as a Potential Oral Short Course Multiple Sclerosis Therapy in the United States 5104 3EMD Serono Submits Application for Cladribine Tablets as a Potential Oral Short Course Multiple Sclerosis Therapy in the United States 5104 4 2416 8 million grant awarded to develop platelet recovery treatments 58550 1 2416 8 million grant awarded to develop platelet recovery treatments 58550 2
Other Biology News:Exhibition showcases the 'art of science' 2Exhibition showcases the 'art of science' 3Mothers give interloper's offspring a head start in life 2Mothers give interloper's offspring a head start in life 3Human role in Indonesian polluting forest fires -- Guido van der Werf in Nature Geoscience 2
Biology Products:
Sheep Anti-Bovine BETA-LACTOGLOBULIN A Polyclonal Antibody, Unconjugated from AbD SerotecRat Anti-STENOTROPHOMONAS MALTOPHILIA Polyclonal Antibody, Unconjugated from AbD SerotecRecorder, 6", 7 Day, 1 Pen, 0 to 100C, Free Standing, 115V, 50/60 Hz, for 4520, Customer Installed from Thermo ScientificRabbit Anti-Human COP9 signalosome complex subunit 2 Polyclonal Antibody, Unconjugated from Aviva Systems Biology
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |